beta-hydroxyisovaleric acid has been researched along with Cachexia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Higaki, Y; Kunitake, N; Kuroki, K; Masuda, M; Rikimaru, F; Toh, S | 1 |
| Holeček, M | 1 |
| Jo, E; Khamoui, AV; Kim, JS; Lee, WJ; Park, BS | 1 |
| Bonatto, SJ; Brito, GA; Fernandes, LC; Kryczyk, M; Kuczera, D; Mund, RC; Nunes, EA; Tanhoffer, RA; Yamazaki, RK | 1 |
| Aversa, Z; Baccino, FM; Bonetto, A; Costelli, P; Lucia, S; Minero, VG; Muscaritoli, M; Penna, F; Rossi Fanelli, F | 1 |
| Lemmey, A; Maddison, P; Marcora, S | 1 |
| Baxter, JH; Eley, HL; Mukerji, P; Russell, ST; Tisdale, MJ | 1 |
| Berk, L; Hug, E; James, J; Kachnic, L; Mahadevan, A; Samuels, M; Schwartz, A | 1 |
| Abumrad, NN; Barber, A; D'Olimpio, JT; Hourihane, A; May, PE | 1 |
2 review(s) available for beta-hydroxyisovaleric acid and Cachexia
| Article | Year |
|---|---|
Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions.
Topics: Animals; Cachexia; Dietary Supplements; Health; Humans; Muscle Strength; Muscle, Skeletal; Muscular Atrophy; Sarcopenia; Valerates; Wasting Syndrome | 2017 |
β-Hydroxy-β-methylbutyrate as a countermeasure for cancer cachexia: a cellular and molecular rationale.
Topics: Animals; Cachexia; Humans; Muscle, Skeletal; Neoplasms; Proteolysis; Signal Transduction; Valerates | 2013 |
4 trial(s) available for beta-hydroxyisovaleric acid and Cachexia
| Article | Year |
|---|---|
Efficacy of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine for the prevention of mucositis induced by platinum-based chemoradiation in head and neck cancer: A phase II study.
Topics: Arginine; Cachexia; Chemoradiotherapy; Glutamine; Head and Neck Neoplasms; Humans; Mucositis; Squamous Cell Carcinoma of Head and Neck | 2023 |
Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial.
Topics: Arginine; Arthritis, Rheumatoid; Body Composition; Body Mass Index; Cachexia; Dietary Supplements; Double-Blind Method; Female; Glutamine; Hand Strength; Humans; Male; Middle Aged; Surveys and Questionnaires; Valerates | 2005 |
A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122).
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Arginine; Cachexia; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Female; Glutamine; Humans; Male; Middle Aged; Neoplasms; Placebos; Plethysmography; Quality of Life; Statistics, Nonparametric; Treatment Outcome; Valerates | 2008 |
Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine.
Topics: Aged; Arginine; Body Composition; Cachexia; Dietary Supplements; Double-Blind Method; Drug Combinations; Female; Glutamine; Humans; Male; Middle Aged; Muscle, Skeletal; Neoplasms; Treatment Outcome; Valerates | 2002 |
3 other study(ies) available for beta-hydroxyisovaleric acid and Cachexia
| Article | Year |
|---|---|
Beta-hydroxy-beta-methylbutyrate supplementation reduces tumor growth and tumor cell proliferation ex vivo and prevents cachexia in Walker 256 tumor-bearing rats by modifying nuclear factor-kappaB expression.
Topics: Animals; Cachexia; Carcinoma 256, Walker; Cell Division; Glycogen; Liver; Male; Muscle, Skeletal; NF-kappa B; Rats; Rats, Wistar; Valerates | 2008 |
β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia.
Topics: Animals; Body Weight; Cachexia; Down-Regulation; Drug Evaluation, Preclinical; Male; Muscle, Skeletal; Muscular Atrophy; Neoplasms; Neoplasms, Experimental; Random Allocation; Rats; Rats, Wistar; Valerates; Weight Loss | 2011 |
Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cachexia; Carrier Proteins; Cell Cycle Proteins; Cells, Cultured; Eukaryotic Initiation Factors; Male; Mice; Mice, Inbred Strains; Muscle Fibers, Skeletal; Muscle Neoplasms; Muscle, Skeletal; Neoplasm Transplantation; Phosphoproteins; Phosphorylation; Protein Biosynthesis; Protein Kinases; Proteoglycans; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases; Valerates | 2007 |